: "Chinese-Brazilian cooperation in science and health reaches a new level"
The two countries are going to sign an agreement that creates the Sino-Brazilian Center for Research and Prevention of Infectious Diseases. The announcement of the unprecedented agreement is scheduled for this Thursday, in Beijing.
This is an initiative of Fiocruz and the CAS-TWAS Center of Excellence for Emerging Infectious Diseases (CEEID), through the Institute of Microbiology of the Chinese Academy of Sciences. The Oswaldo Cruz Foundation (
Fiocruz) is the most prominent Institution of Science and Technology in Health in Latin America, based in Brazil.
The center will also develop rapid diagnostic tests, therapies, vaccines and drugs.
Among the diseases that will be studied, some affect both countries, such as Covid-19. Others, such as yellow fever, affect Brazil more, but have attracted Chinese interest.
Brazil and China share the vision of healthcare as public goods, such as vaccines, medicines and diagnostic tests.